Next Article in Journal
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests
Previous Article in Journal
Defective Thyroglobulin: Cell Biology of Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Involvement of Oxytocin and Progesterone Receptor Expression in the Etiology of Canine Uterine Inertia

by
Carolin Jungmann
1,
Caroline Gauguin Houghton
2,
Frederik Goth Nielsen
2,
Eva-Maria Packeiser
1,
Hanna Körber
1,
Iris M. Reichler
3,
Orsolya Balogh
3,4,† and
Sandra Goericke-Pesch
1,*,†
1
Reproductive Unit, Clinic for Small Animals, University of Veterinary Medicine Hannover, 30559 Hanover, Germany
2
Section for Veterinary Reproduction and Obstetrics, Department of Clinical Veterinary Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark
3
Clinic of Reproductive Medicine, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland
4
Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2022, 23(21), 13601; https://doi.org/10.3390/ijms232113601
Submission received: 11 October 2022 / Revised: 29 October 2022 / Accepted: 1 November 2022 / Published: 6 November 2022
(This article belongs to the Section Molecular Endocrinology and Metabolism)

Abstract

:
An altered oxytocin and progesterone receptor (OXTR and PGR, respectively) expression was postulated in canine uterine inertia (UI), which is the lack of functional myometrial contractions. OXTR and PGR expressions were compared in uterine tissue obtained during C-section due to primary UI (PUI; n = 12) and obstructive dystocia (OD, n = 8). In PUI, the influence of litter size was studied (small/normal/large litter: PUI-S/N/L: n = 5/4/3). Staining intensity in immunohistochemistry was scored for the longitudinal and circular myometrial layer and summarized per dog (IP-Myoscore). Mean P4 did not differ significantly between PUI (n = 9) and OD (n = 7). OXTR and PGR expressions (ratios) were significantly higher in PUI (OXTR: p = 0.0019; PGR: p = 0.0339), also for OXTR in PUI-N versus OD (p = 0.0034). A trend for a higher PGR IP-Myoscore was identified (PUI-N vs. OD, p = 0.0626) as well as an influence of litter size (lowest PGR-Myoscore in PUI-L, p = 0.0391). In conclusion, PUI was not related to higher P4, but potentially increased PGR availability compared to OD. It remains to be clarified whether OXTR is upregulated in PUI due to a counterregulatory mechanism to overcome myometrial quiescence or downregulated in OD due to physiological slow OXTR desensitization associated with an advanced duration of labor. Identified OXTR differences between myometrial layers indicate the need for further research.

1. Introduction

Uterine inertia (UI) is, with approximately 75%, the most common maternal cause of dystocia in the pregnant bitch [1,2]. Regardless of the varying criteria applied by the different authors [1,3,4], UI is generally divided into primary and secondary UI [2]. Primary uterine inertia (PUI) is characterized by the absence of functional myometrial contractions preventing natural delivery despite normal-sized fetuses and a patent birth canal. Secondary uterine inertia (SUI) is caused by myometrial exhaustion due to obstruction, usually after one or several pups have already been expelled [1,2,3,5]. As uterine inertia possesses a high risk for maternal health and fetal survival, early recognition and rapid treatment are paramount [1,6]. However, conservative medical treatment, consisting of oxytocin, calcium, dextrose, or denaverine alone or in combination [1,6,7], often remains unsuccessful and, thus, an emergency Cesarean section (C-section) is required in over 60% of canine dystocia cases [1,6,8,9]. As a result, C-sections are frequently considered as the first choice without any prior medical treatment attempts [7,10].
Despite its high incidence, the etiology of PUI is poorly understood so far. Nevertheless, predispositions have been described for several breeds [3,11,12,13] as well as risk factors, such as maternal overweight, advanced age, very small or large litter size, and hormonal, electrolyte, or metabolic imbalances [1,2,3,6,10,12,14,15]. Additionally, alterations in the expressions of basic contractile and contractility associated proteins in the uterus, e.g., smooth muscle γ-actin, smooth muscle myosin [16], the RhoA/Rho associated kinase pathway, and leptin signaling [17], were found in cases of PUI.
Parturition is a delicately orchestrated endocrine event with progesterone (P4), prostaglandins, and oxytocin playing key roles, not only in the dog [18,19]. Different studies have looked deeper into peripheral hormone concentrations during canine parturition in general and specifically in UI [14,15,20,21,22]. The onset of labor is inseparable from luteolysis and, thus, P4 withdrawal, as high plasma P4 levels mediate myometrial quiescence and prevent uterine contractions [23,24]. In contrast to luteal regression in nonpregnant bitches, the slow regression is accelerated around day 60 of pregnancy, when reaching a lower threshold level activates the prepartum luteolytic cascade [25,26,27]. The following steep decline in P4 is accompanied by a large increase in PGF2α-metabolite (PGFM) concentrations [22,26], indicating active luteolysis. Feto-maternal communication seems to play a crucial role in activating the prostaglandin system and, thus, the prepartum PGF2α release (reviewed in [28]). Interestingly, a significantly higher P4:PGFM ratio in dystocic bitches supporting the postulated failure of luteolysis in PUI [20,29,30,31] was found in one study [20], but not in another [32], emphasizing the complexity of UI. In addition to P4, expression of the P4 receptor (PGR) likely plays a pivotal role in pregnancy and parturition as indicated by decreased PGR expression in uterine tissue close to term (day 60 after the LH surge) [33]. Although the hormonal mechanisms behind the regulation and expression of PGR in the corpus luteum and placenta in relation to parturition have already been investigated for the dog [27,34,35,36,37], research on (myometrial) PGR expression, especially related to dystocia and PUI, is still lacking.
Another potent uterotonic hormone crucially required for parturition and expulsion of the fetuses is oxytocin (OXT). OXT enhances the contractility of the myometrium through binding to its G protein coupled receptor (OXTR), activating the protein kinase type C (PKC) pathway [38]. During birth, OXT is released from the neurohypophysis as a response to intracervical pressure, activating uterine contractions (Ferguson’s-reflex) [39]. As OXT sensitivity is significantly increased around canine parturition due to upregulation of OXTR expression [33,40,41], low OXT concentrations [10,42] or abnormal OXTR expression could contribute to the occurrence of PUI. Furthermore, in cattle [43] and sheep [44], OXT was shown to affect the release of prostaglandins, primarily PGF2α, and to induce the expression of the uterine prostaglandin-endoperoxide synthase 2 (PTGS2), additionally stimulating uterine contractility indirectly. Although OXTR might play a significant role in canine UI, information about its expression in dystocic bitches is limited to the mRNA level [32], not allowing for a final conclusion about its role in canine UI.
Summarizing the current state of knowledge, it is obvious that the role of P4 and OXT and their receptors in canine parturition and canine UI require further elucidation, not only for a deeper understanding of the physiology and pathophysiology, but also to optimize medical treatment options and to develop possible preventive strategies. Consequently, this study investigated the expression of PGR and OXT in bitches diagnosed with PUI and OD, hypothesizing altered expressions in canine PUI.

2. Results

2.1. Determination of Serum P4 Concentrations

P4 concentrations ranged between 1.3 and 4.6 ng/mL independent of groups. The unpaired t-test revealed no significant differences when comparing PUI and OD (Figure 1).

2.2. OXTR Expression

OXTR IP mRNA expression (ratio) differed significantly between PUI and OD (p = 0.0019) with a higher expression in PUI (Figure 2a). Similarly, OXTR IP gene expression was significantly increased in PUI-N compared to OD (p = 0.0034) (Figure 2b). In contrast, no effect of litter size on OXTR IP mRNA expression was found within the PUI group (Figure 2d). Likewise, a comparison of OXTR expression between PUI and OD at UP or between IP and UP (PUI and OD summarized) revealed no significant differences (Figure 2c,e).
Specific staining for OXTR was observed in the perinuclear area of the myocytes in both myometrial layers and, less intensely, in endometrial stromal cells (Figure 3). In addition, maternal decidual cells and capillary pericytes stained positively for OXTR in the placenta.
No significant differences were identified in terms of OXTR staining between dystocia groups, neither individually in the longitudinal and circular myometrial layer nor in the summarized IP-Myoscore (Supplementary Materials, Table S2). In addition, OXTR staining was not influenced by litter size (Supplementary Materials, Table S3). However, independent of groups (PUI, OD, and PUI + OD), OXTR staining intensity was significantly stronger in the circular compared to the longitudinal layer in IP with the difference becoming even more obvious when combining both localizations (IP + UP) (p < 0.001; Figure 4; Supplementary Materials, Table S1). Tables S1–S3 in Supplementary Materials contain all statistical analysis regarding differences in OXTR staining intensity between myometrial layers and groups.

2.3. PGR Expression

In IP, a significantly higher PGR mRNA expression (ratio) was observed in PUI compared to OD (p = 0.0339), with a similar trend identified when comparing PUI-N and OD (p = 0.0524) (Figure 4). This effect was not observed in UP samples. In addition, litter size did not have an impact on PGR expression, and neither were differences identified between IP and UP (Figure 5d,e).
In IHC, myometrial smooth muscle cells stained strongly positive for PGR. Additionally, a specific immunopositive signal was detected in endometrial stromal cells, uterine glandular cells, and luminal epithelial cells. In the placenta, only maternal decidual cells stained PGR-positive (Figure 6).
Statistical analysis of PGR IHC results is given in the Supplementary Materials (Tables S4–S6). The PGR staining score did not differ between the longitudinal and circular myometrial layer (Supplementary Materials, Table S4). Comparison of PGR IP-Myoscore from PUI and OD samples did not reveal significant differences but a tendency of higher staining intensity in PUI that was also evident for PUI-N versus OD (Figure 7, Supplementary Materials, Table S5). Litter size influenced PGR expression (p = 0.0391), with the lowest score in PUI-L compared to PUI-N/S. (Figure 7). This effect was also apparent when comparing the results of the longitudinal myometrial layer (Kruskal–Wallis, p = 0.0306), but not of the circular layer (Supplementary Materials, Table S6).

3. Discussion

Despite the frequent occurrence of PUI in dogs and its severe consequences for maternal and offspring survival, the exact etiology is still unknown. Up to now, only few studies have investigated its pathophysiology from a molecular biology approach looking directly at the level of the uterus [16,17,32,45,46]. As both oxytocin and progesterone are crucial hormones during parturition, we hypothesized and identified altered expression of the respective receptors as potential causes for PUI.
The expression of the OXTR at the mRNA and protein level, in relation to pregnancy and normal, undisturbed parturition, has already been extensively studied [32,40,41]. However, by now, only Tamminen et al. [32] investigated a possible role of OXTR mRNA expression in the context of dystocia in dogs, using full-thickness uterine tissues obtained from the incision site during C-sections. They identified the lowest OXTR expression in OD bitches, with the expression being significantly lower than in bitches presented for elective C-section because of small litter size before term or previous dystocia (ECS). Although OXTR expression was lower in OD compared to complete uterine inertia (CUI), the difference was not significant [32]. It remains to be clarified whether the identified OXTR differences were related to the smaller litter size (singleton or two puppies) in some ECS bitches or to the differences in the endocrine situation of prepartum (ECS) and intrapartum (OD) bitches, as parturition is a sensitive orchestrated endocrine event with significant changes occurring within the last 24 h before initiation of labor [24,47,48]. Samples from ECS bitches likely do not represent the physiological situation (including gene and protein expression) during canine parturition and this is a—however ethically easy to understand—limitation of this and our own study, too, that no uterine tissue samples of eutocic bitches were included for comparison.
Nevertheless, Tamminen et al. [32] suggested that OXTR was downregulated in OD due to prolonged action of OXT, leading to myometrial exhaustion. In human myometrium, a physiological slow OXTR desensitization, accompanied by OXTR mRNA downregulation, proceeds with an advanced duration of labor [49]. Assuming a homologous event in dogs as described before in women, decreased OXTR mRNA expression in OD, as also observed in our study, might be caused by a prolonged labor itself or altered (accelerated in this case) OXTR desensitization. Furthermore, prolonged intracervical pressure, resulting in increased hypophyseal OXT release, could contribute to this desensitization. A decreased mRNA expression of other contractile and contractility associated proteins in IP sections of OD compared to PUI bitches has also been shown in our previous reports [16,17], corroborating the current findings and the proposed role of prolonged labor contractions on the uterus. Indeed, all OD bitches included in our study still showed strong straining as a response to digital vaginal feathering and spontaneous abdominal and/or uterine contractions, indicating that these bitches did not reach myometrial fatigue, causing secondary UI. Although pregnancy regulation in the dog has not been fully elucidated until now, normal parturition is associated with a rapid progesterone decline in response to increased luteolytic concentrations of prostaglandins, mediated by placental feto-maternal crosstalk, allowing strong aligned uterine contractions [27,40,50]. The significantly higher OXTR mRNA expression (ratio) in IP samples obtained from PUI (and PUI-N) dams compared to OD might be a consequence of the absence of intracervical pressure due to the fact that no puppy had been born and, thus, having insufficient systemic OXT release, as previously postulated by Tamminen et al. [32]. It is worth noting that comparison of the OD and PUI samples was shown to be suitable in previous studies to gain further insight into the pathophysiology of canine dystocia and specifically PUI [15,16,17,32,45,46].
At the protein level, localization of OXTR expression was in accordance with other authors [40,51,52]. They described a strong immunopositive signal in the uterine surface epithelium, superficial uterine glands, vascular endothelial cells, and stroma cells of the endometrium in early pregnancy that becomes noticeably weaker during prepartum luteolysis [40]. Similar to our results, a strong signal was localized in placental decidual cells and capillary pericytes and the myocytes of both myometrial layers [40,51]. Thus, our findings confirm the previously described colocalization with PGR in the placenta. This suggests that OXTR is involved in the signaling cascade, possibly resulting in an increased prepartum output of luteolytic PGF2α by blocking PGR function [40,50].
The significant differences in OXTR expression between groups obtained at the mRNA level using full-thickness uterine tissues were not confirmed when considering myometrial staining only as identified by IHC. Various explanations for this phenomenon are possible including limited suitability of IHC for protein quantification, subjectivity of the investigators, and slight changes in the environmental settings [53]. As Gram et al. [40] identified the highest OXTR expression in the myometrium compared to endometrium and placenta when investigating uteroplacental compartmentalization, it seems appropriate to focus on myometrial OXTR protein expression. Moreover, the observed disparity of results might be due to a difference between the possible transcription of OXTR mRNA and actual translation and, thus, expression of the receptor at the protein level. Likewise, the increased OXTR mRNA expression in PUI might induce a subsequent upregulation of the OXTR protein expression, possibly to increase responsiveness in the case of insufficient OXT release/availability. Low OXT concentrations in the peripheral blood had been identified earlier and postulated to be involved in the etiology of PUI in a cohort of dogs [20]. Consequently, an increased OXTR availability might be a counterregulatory mechanism to increase responsiveness to low OXT levels to successfully expel puppies. Although determination of peripheral blood OXT concentrations would have provided valuable information, it was not included in this study, due to well-known difficulties in analysis because of the short half-life [54], its strong binding to other molecules, and possible tests’ cross-reactivity [31].
Interestingly, significant differences in OXTR protein expression between the two myometrial layers were identified in IP samples. Evidence for distinctions in function, morphology, and innervation between myometrial layers have already been described for rats [55], rabbits [56], pigs [57], and cattle [58,59]. An ex vivo organ bath study, investigating the contraction behavior of canine periparturient and parturient myometrium, performed by our working group, supports the current findings of OXTR expression being significantly increased in the circular layer [60]. In these experiments, the circular myometrial layer visually showed a better response to oxytocin stimulation compared to the longitudinal layer, especially when using higher OXT concentrations [60]. In contrast to this, Gogny et al. [61] described a greater contractile response to OXT in the longitudinal compared to the circular myometrial layer of cyclic healthy bitches in anestrus or metestrus with and without Aglepristone treatment. Recently, our working group investigating the role of prostaglandins in PUI identified a significant difference in PTGS2 staining between myometrial layers, with PTGS2 being higher-expressed in the longitudinal layer of the same samples [46]. Taken together, all studies suggest a complex regulation of myometrial contractile activity during parturition with coordinated action of the two myometrial layers in canine uterine tissues being essential for eutocia. Although some studies have investigated functions of myometrial contractions in delivering the offspring in pigs [62,63,64], mice [65], and cattle [66], little is known about the mechanisms in the dog. It can be assumed that birth mechanisms in the dog, another polytocous species, are similar to the porcine mechanisms with caudally (toward the cervix) and cranially (away from the cervix) directed contractions moving the piglets forward and backward within the uterine horn during the expulsive stage [64]. Similar alternating patterns of fetal expulsion from collateral horns were described for both species [63,67,68]. However, the significance of the two myometrial layers and their postulated different functions in this context urgently requires further investigation. Differentiating the longitudinal and circular myometrial layer individually for layer-specific analysis of OXTR gene expression by qPCR and OXTR protein quantification by Western blotting could further support our results and hypothesis.
Another endocrine event of utmost importance for canine parturition and functional myometrial contractions due to sensitization to OXT is the prepartum progesterone drop [41]. Failure of luteolysis and, thus, higher serum P4 concentrations have been discussed to be related to PUI [2,20]. In addition to P4 itself, an important role of PGR for (normal) parturition was postulated in the dog [28,50]. For this reason, P4 and PGR in canine PUI and OD patients were analyzed, without identifying a significant difference, however. Interestingly, and other than expected and previously postulated [20,29,30,31], we identified no significant differences between P4 serum concentrations in PUI compared to OD, clearly showing that, at least in our cohort, PUI was not due to inadequate luteolysis. To gain further insights into the role of PGR for canine parturition and based on the hypothesis that PGR expression is altered in PUI, our working group was the first investigating PGR mRNA and protein expression in relation to canine dystocia. PGR mRNA expression was significantly higher in PUI compared to OD in IP samples, with the same trend observed for PUI-N. These findings suggest increased sensitivity of the uterus even in cases of low circulating P4 concentrations, possibly resulting in a higher degree of inhibition of myometrial contractions in PUI compared to OD, contributing to the failure of contractions. Two PGR isoforms, A and B, exist due to the use of alternative translation initiation sites. Peavey et al. [69] identified opposing actions of the two isoforms on myometrial contractility in mice. Whereas PGR-B overexpression significantly increased gestation length and hampered uterine contractility as demonstrated by a significantly lower contractile response of the myometrium in an ex vivo dose–response experiment, excessive PGR-A expression induced an intensified contractile response to uterotonic agents [69]. Thus, overexpression of PGR-B resulted in a relaxation of the myometrium and reduced OXTR expression, hindering the myometrium to contract sufficiently when oxytocin was administered. Assuming that in dogs, a similar effect of PGR isoforms exists, increased PGR-B expression in PUI could contribute to the reduced ability to functionally contract. However, as no information about PGR isoform expression is currently available for the dog, except for the mammary gland [70], and the primers and antibody used in this study do not discriminate between the isoforms, the PGR isoforms and their expressions deserve further investigation in the canine uterus, especially, but not only in case of dystocia.
PGR intracellular localization was as previously described in pregnant dogs, with endometrial stromal cells, myometrial smooth muscle cells, and maternal decidual cells staining strongly [71,72]. Although the significant difference between PUI and OD identified in PGR mRNA expression was not confirmed on the protein level, a trend for a higher IP-Myoscore in PUI/PUI-N compared to OD was found. Altered tissue composition (full-thickness uterine tissue for mRNA analysis versus myometrium only for protein IHC scoring) might justify the identification of a trend only. However, local changes in terms of PGR expression related to PUI have to be considered. It remains to be clarified whether this altered PGR expression is involved in the development of PUI or is a result or consequence of inadequate or absent endocrine or mechanical stimuli due to PUI. Unlike the findings for OXTR, PGR expression in the two myometrial layers did not differ. Considering the function of P4 and PGR, namely maintaining pregnancy, it seems evident that inhibition needs to be equal in both layers to successfully prevent contractions before term. Thus, the equal PGR distribution in both layers seems to represent a physiological situation.
Litter size is known to be a potential risk factor for development of PUI in bitches [12] with increased PUI risk described in the case of small (namely singleton) or large litters. Analysis of PGR protein expression related to litter size revealed a significantly lower myometrial PGR expression in the PUI-L group. Myometrial overstretching due to a large litter was already mentioned earlier in relation to UI [3,5,11]. Overstretching could reduce the density of PGRs per cm2, explaining the reduced PGR expression in PUI-L. However, this observation has to be treated with caution, as the PUI-L group is very small (n = 3). Interestingly, no effect of litter size was observed for OXTR in this study, while in the same bitches, an effect on the expression of smooth muscle γ-actin, a basic contractile protein, was found [16]. In conclusion, further studies are necessary to confirm if the etiology and pathophysiology of PUI differ depending on the litter size.
The relatively small sample size might display a limitation of the current study, as proving significance is complicated when comparing smaller groups, such as the PUI-N group. Heterogeneity of the bitches in terms of age, breed, and body weight represents the canine population [46], but might have influenced the present results, too. However, detailed examinations of bitches before surgery, complete medical history, and strict adhesion to inclusion criteria are a large benefit of our studies. In conclusion, to gain more precise insights into canine uterine inertia and possibly dystocia, investigations on a larger population including IP and UP samples should be conducted, with the difficulties in obtaining UP samples (by spaying at the time of C-section) being previously discussed in detail [46]. In addition, breed-specific studies might be considered for comparative use, too.

4. Materials and Methods

4.1. Animals and Study Design

The samples utilized in this study were already used previously by our research group [45,46] and our collaborators [15,16,17].
Full-thickness uterine tissue samples were collected from 20 bitches at term presented for medically indicated emergency C-sections following owner’s consent. Apart from dystocia, the bitches were clinically healthy and received no ecbolic or tocolytic medication before the samples were taken. Detailed general, medical, and reproductive history of all dogs was recorded. The mean age of the bitches included was 4.2 ± 2.1 years, and the mean body weight was 20.1 ± 18.4 kg. All bitches had a thorough physical and obstetrical exam. Fetal heart rates were monitored by abdominal sonography. Additionally, when required for a proper diagnosis and it was feasible in terms of the dam’s and fetal health, radiographs were taken and tocodynamometry was performed. Blood samples were collected pre-surgery to obtain baseline hematology and chemistry including ionized calcium and glucose [15]. In addition, blood was sampled from 16 bitches for retrospective analysis of serum progesterone (P4) concentrations using radioimmunoassay (RIA) [22,25,73].

4.2. Grouping

The grouping of the bitches was as previously described [46]. All inclusion criteria are given below. The bitches were retrospectively assigned to one of the subsequent groups: 1. primary uterine inertia (PUI, n = 12), or 2. obstructive dystocia (OD, n = 8).
Bitches included in the PUI group had failed to deliver any puppy at term, and showed a lack of the Ferguson’s reflex at vaginal stimulation and only weak or no abdominal contractions. Obstruction was ruled out by vaginal examination and X-rays. In addition, the bitches had to show one of the following signs: The prepartum temperature drop was more than 20 h ago or/and signs of first stage labor were shown for ≥20 h or the temperature had already normalized without progression to second-stage labor; no signs of second-stage labor, but green vulvar discharge for >2 h; unproductive, weak, infrequent abdominal contractions for >4 h without progression; or no abdominal contractions, although fetal fluids passed more than 3 h ago. As the litter size was quite variable, the PUI group was subdivided into small/normal/large litter size (PUI-S, PUI-N, PUI-L) in relation to the average litter size of the respective breed [74]. Litter size within the breed average ± 1 standard deviation (SD) was considered as normal (PUI-N), whereas less or more than ± 1 SD was assigned to PUI-S or PUI-L, respectively [15,16,17,45,46].
Bitches diagnosed with OD were used for comparison with PUI. These bitches were in second-stage labor but failed to deliver due to obstruction of the birth canal, as confirmed by digital vaginal palpation and/or abdominal X-ray. However, they were still showing strong abdominal contractions, either spontaneously or in response to feathering (digital vaginal stimulation). These obviously functional contractions provided the basis for our assumption that OD is suitable for comparison with PUI. The litter size of all OD bitches was normal compared to the described average litter size of the breed [74].
Bitches with signs of a systemic illness or other risk factors for UI were excluded from the study.

4.3. Tissue Sample Collection and Processing

During medically indicated C-section, uterine tissue samples were obtained after all puppies had been delivered. A full-thickness tissue biopsy, approximately 0.5–1 cm wide, was taken from the interplacental (IP) tissue (between two placentation sites) along the uterine incision line. If a concomitant ovariohysterectomy (Sectio Porro) was medically indicated or requested by the owner, IP samples were collected after extraction of the uterus and additional tissue stripes from utero-placental sites (UP) and the placenta were taken.
Collected tissue was divided into different parts for subsequent mRNA and protein analysis, as well as for histology and immunohistochemistry (IHC) as previously described [45,46]. For mRNA analysis, samples were covered with RNAlater® (Ambion Biotechnologie GmbH, Wiesbaden, Germany) immediately post-surgery, temporarily stored at 4 °C, before being kept at −80 °C until extraction. For histology and IHC, tissue samples were fixed in 10% neutral phosphate-buffered formalin for 24 h at 4 °C, washed regularly with phosphate-buffered saline for several weeks, and subsequently embedded in paraffin.

4.4. RNA Isolation and Reverse Transcription

RNA isolation using a Trizol (SIGMA-ALDRICH CHEMIE GmbH, Steinheim, Germany)-based protocol was performed as previously described [45,46]. To evaluate and measure the extracted mRNA concentrations, an IMPLEN NanoPhotometer® (IMPLEN GmbH, Munich, Germany) was used.
Reverse transcription for full-length first-strand cDNA was performed with DNase-pretreated RNA (200 ng/µL) and the RevertAidFirst Strand cDNA synthesis Kit (#K1622, Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s instructions and as previously described [45,46]. cDNA was stored at −20 °C until further use. Specific primer sets for both OXTR and PGR for quantitative real-time polymerase chain reaction (RT-qPCR) were purchased from TAG Copenhagen (TAG Copenhagen A/S, Copenhagen, Denmark) and primers for the reference genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH), protein tyrosine kinase 2 (PTK2), eukaryotic translation initiation factor 4H (EIF4H), and lysine-specific demethylase 4A (KDM4A) [75] from Microsynth (Microsynth AG; Balgach, Switzerland) (Table 1). The specificity of the primers was checked with BLAST (http://blast.ncbi.nlm.nih.gov, accessed on 3 August 2021).
For RT-qPCR, a LightCycler® 96 real-time PCR system (Software version 1.1.0.1320, Roche Diagnostics GmbH, Mannheim, Germany) was used, running all samples in triplicates according to our previously published protocol [76]. Cycling conditions of the RT-qPCR were as previously established [45,46,76]. RNase-free water served as the non-template control. The standard curves for target and reference genes were prepared by using pooled twofold-diluted series of cDNA (1:2-1:128) run as triplets to calculate PCR efficiencies (respective efficiencies given in Table 1). Analysis of the RT-qPCR results was performed using a modified model of the efficiency-corrected relative quantification according to Pfaffl [77], taking into account the expression of multiple reference genes for improved normalization [78]. As the model assumes stable expression of genes in the tissue, only GAPDH and PTK2 (stable expression), but not KDM4A and EIF4H (unstable expression), were taken into consideration for normalization. Specific primer binding was confirmed by sequencing the PCR products (Microsynth AG).

4.5. Immunohistochemistry for OXTR and PGR and Evaluation of the Staining

For immunohistochemistry (IHC), sections of formalin-fixed, paraffin-embedded uterine tissue (3 µm) mounted on SuperFrost-Plus slides (Menzel Glaeser, Braunschweig, Germany) were treated following our previously published protocol [45,76]. After deparaffinization, rehydration, and antigen retrieval, blocking of unspecific binding sites was performed using 10% horse serum with 5% bovine serum albumin in ICC buffer for OXTR and 10% goat serum in PBS (ROTI® Fair PBS 7.4, Carl Roth GmbH + Co. KG, Karlsruhe, Germany) for PGR, before samples were incubated with the respective first antibody (OXTR/PGR) overnight. All details about antibodies and dilutions are given in Table 2. Negative (buffer only) and isotype controls (Table 2) at the same protein concentration were included in each run. On the second day, the protocol differed considerably for detection of OXTR and PGR: for OXTR, a two-step horseradish peroxidase conjugated polymer system with DAB as a chromogen (SuperVision 2 HRP KIT PD000KIT; DCS Innovative Diagnostik-Systeme, Hamburg, Germany) was used according to the manufacturer’s instructions. For PGR, slides were incubated with the secondary antibody in 10% horse serum. Visualization of the immunopositive signal was performed with an immunoperoxidase system (VECTASTAIN PK-6100 ABC-Elite Standard: HRP and Vector Nova-RED Substrate Kit SK-4800; Vector Laboratories, Burlingame, CA, USA) according to the manufacturer’s instructions as previously described [76]. Then, all slides (OXTR/PGR) were counterstained with hematoxylin and dehydrated in increasing alcohol concentrations (70%, 96%, and 99%) and xylene before embedding with HistoKit (Assistant, Osterode, Germany). To avoid any bias due to differences between runs and to allow for better comparison, all samples were included in one run for OXTR and PGR each.
For evaluation of the staining, slides were visually examined under a light microscope (Olympus Bx 45, Olympus Europa SE & Co. KG, Hamburg, Germany) by two independent, blinded investigators. The localization of the immunopositive signals was evaluated descriptively. In addition, the staining intensity of the longitudinal and circular myometrial layer was scored independently and graded semi-quantitatively by both investigators, using an ordinal score system (1: weak, 2: moderate, and 3: strong staining). Results of the myometrial staining (mean of both investigators) were subjected to statistical comparisons (see below). In addition, the longitudinal and circular myometrial staining results of each dog were summarized as IP-Myoscore.

4.6. Statistical Analysis

Statistics was performed using Microsoft Excel 2016 (Microsoft Corporation, Redmond, WA, USA) and Graph Pad Prism9 software (GraphPad Software, Inc., La Jolla, CA, USA). The Shapiro–Wilk test was used to test for normal distribution. Data were presented as the arithmetic mean and standard deviation [x ± SD] when normally distributed. If not passing the test for normality, data were presented as the geometric mean and dispersion factor [xg (DF)]. Statistical differences were considered significant at a level of p ≤ 0.05.
The aim of the current research was to contribute to a better understanding of uterine inertia, by comparing PUI to OD data. Due to variable litter size in PUI, PUI-N was compared to OD, with litter size in OD being considered as normal according to earlier literature [45,74]. Datasets were separately evaluated for IP and UP. In addition, the impact of litter size was studied by comparison of PUI-S, PUI-N, and PUI-L in the IP samples.
To detect differences between P4 concentrations in PUI (n = 9) and OD (n = 7), an unpaired t-test was used as data were normally distributed.
For analysis of gene expression, most raw data were normally distributed. For the remaining (OXTR: PUI versus OD (UP); PGR: PUI-S versus PUI-N versus PUI-L), log transformation of data was performed revealing a normal distribution of log-transformed data according to the Shapiro–Wilk test. Subsequently, an unpaired t-test was used for comparison of PUI versus OD (IP/UP separately), PUI-N versus OD (IP only due to group size), and IP versus UP (summarizing PUI and OD) using the respective (raw/log-transformed) datasets. The influence of litter size (PUI-S versus PUI-N versus PUI-L) was studied using an ANOVA followed by Tukey’s multiple comparisons test if the ANOVA revealed p < 0.05. For a homogeneous data presentation and to ensure comparability, all gene expression results were presented as mean ± SD.
As a key role of OXTR and PGR in the myometrial layers was postulated in PUI, the immunohistochemical staining intensity was scored individually by two independent, blinded investigators for the longitudinal and circular myometrial layer. Calculation of Cohen’s kappa value [79] was used to assess inter-evaluator agreement for scoring of staining results. As the weighted K coefficient (κ = 0.89) revealed high inter-evaluator agreement, suggesting high comparability of the results of both investigators, the means of the semi-ordinal scores of both investigators were used for comparison of the individual myometrial layers (longitudinal/circular) between groups and for the different uterine localizations (i.e., PUI/OD IP/UP longitudinal versus PUI/OD IP/UP circular; PUI IP longitudinal/circular versus OD IP longitudinal/circular). Furthermore, all longitudinal myometrial staining results (PUI and OD summarized) were compared to all circular myometrial staining results (PUI and OD summarized) from IP and UP samples separately (PUI + OD IP longitudinal versus PUI + OD IP circular) and combining all layer-specific staining results from both localizations (all longitudinal IP + UP versus all circular IP + UP). In addition, the overall IP-Myoscore was calculated for each group and used for group-wise comparison (IP-Myoscore PUI versus IP-Myoscore OD). As none of the datasets were normally distributed following the Shapiro–Wilk test, either a Wilcoxon matched-pairs signed rank test for paired data or a Mann–Whitney test for unpaired data was carried out. Finally, the influence of litter size was studied as described above, comparing the separate layers and the IP-Myoscore using a Kruskal–Wallis test, followed by Dunn’s multiple comparisons test if p < 0.05.

5. Conclusions

As hypothesized, OXTR and PGR expression were altered in PUI. However, other than expected, both receptors were upregulated in PUI compared to OD. Whereas increased PGR expression might possibly potentiate the effect of the remaining circulating P4 by more effective binding, thereby inhibiting effective contractions, it remains to be clarified if upregulation of OXTR is a counterregulatory mechanism. In addition, the identified heterogeneity in OXTR protein expression between both myometrial layers, with a stronger staining in the circular myometrial layer, indicates functional differences that require further research for a better understanding of canine uterine contractility.
In conclusion, the numerous results of this and our other recent studies [15,16,17,45,46] give promising new clues to potential causes of PUI, but also indicate novel approaches for further research and contribute to a better understanding of myometrial contractility. Clarifying PUI is important not only to understand its underlying etiology but also to identify other treatment options in addition to surgery.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms232113601/s1, Table S1: Statistical analysis of OXTR-immunopositive staining. Comparison of layers: longitudinal versus circular myometrial layer differentiated in interplacental (IP) and uteroplacental (UP) tissue. Groups (primary uterine inertia, PUI; obstructive dystocia, OD) are presented individually and summarized. Table S2. Statistical analysis of OXTR-immunopositive staining in interplacental (IP) tissue. Comparison of groups (primary uterine inertia, PUI, versus obstructive dystocia, OD) for each specific myometrial layer (longitudinal/circular) and the combined IP-Myoscore. Table S3. Effect of litter size in the primary uterine inertia (PUI) group on OXTR-immunopositive staining in IP tissue differentiating the myometrial layer (longitudinal/circular). PUI bitches with normal litter size (PUI-N, average litter size of the respective breed ±1 standard deviation) were compared with litters smaller (PUI-S, <−1 SD) or larger (PUI-L, >+1 SD) than the breed average. Table S4. Statistical analysis of PGR-immunopositive staining. Comparison of layers: longitudinal versus circular myometrial layer differentiating interplacental (IP) and uteroplacental (UP) tissue. Groups (primary uterine inertia, PUI; obstructive dystocia, OD) were presented individually and summarized. Table S5. Statistical analysis of PGR-immunopositive staining in interplacental (IP) samples. Comparison of groups (primary uterine inertia, PUI, versus obstructive dystocia, OD) depending on localization (interplacental, IP; uteroplacenta, UP) and specific myometrial layer (longitudinal/circular) or combined IP-Myoscore. Table S6. Effect of litter size on PGR-immunopositive staining in interplacental (IP) samples of the primary uterine inertia (PUI) group differentiating the myometrial layers (longitudi-nal/circular). PUI bitches with normal litter size (PUI-N, average litter size of the respective breed ±1 standard deviation) were compared with litters smaller (PUI-S, <−1 SD) or larger (PUI-L, >+1 SD) than the breed average.

Author Contributions

Conceptualization, C.J., I.M.R., O.B. and S.G.-P.; sample collection, I.M.R., O.B. and S.G.-P.; formal analysis, C.J., E.-M.P. and S.G.-P.; funding acquisition, C.J. and S.G.-P.; investigation, C.J., C.G.H., F.G.N., E.-M.P., H.K. and S.G.-P.; methodology, E.-M.P. and S.G.-P.; project administration, S.G.-P.; resources, S.G.-P.; supervision, S.G.-P.; visualization, C.J., H.K. and S.G.-P.; writing—original draft, C.J., E.-M.P., H.K. and S.G.-P.; writing—review and editing, C.J., C.G.H., F.G.N., E.-M.P., H.K., I.M.R., O.B. and S.G.-P. All authors have read and agreed to the published version of the manuscript.

Funding

Carolin Jungmann, DVM, received financial support by a grant of Bayer® AG (Leverkusen, Germany) and the “Gesellschaft der Freunde der Tierärztlichen Hochschule Hannover e.V.”. This Open-Access publication was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—491094227 “Open Access Publication Funding” and the University of Veterinary Medicine Hannover, Foundation.

Institutional Review Board Statement

The animal study protocol was approved by the Animal Experiments Inspectorate, Danish Veterinary and Food Administration, Ministry of Food, Agriculture and Fisheries of Denmark (permit no. 2015-15-0201-00513), and by the cantonal committee on animal experimentation of the Cantonal Veterinary Office Zurich (permit no. ZH086/15).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in Supplementary Materials of this paper. Further datasets are available on request from the corresponding author.

Acknowledgments

The technical assistance of Sabine Feller (endocrinological laboratory Gießen) for progesterone analysis is gratefully acknowledged.

Conflicts of Interest

The authors declare that they do not have any financial and personal relationships with other people or organizations that could inappropriately bias or influence their work.

References

  1. Darvelid, A.W.; Linde-Forsberg, C. Dystocia in the bitch: A retrospective study of 182 cases. J. Small Anim. Pract. 1994, 35, 402–407. [Google Scholar] [CrossRef]
  2. Davidson, A.P. Primary Uterine Inertia in Four Labrador Bitches. J. Am. Anim. Hosp. Assoc. 2011, 47, 83–88. [Google Scholar] [CrossRef] [PubMed]
  3. Linde Forsberg, C.; Persson, G. A survey of dystocia in the Boxer breed. Acta Vet. Scand. 2007, 49, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Feldman, E.; Nelson, R. Canine and Feline Endocrinology and Reproduction, 3rd ed.; WB Saunders: Philadelphia, PA, USA, 2004; pp. 752–805. [Google Scholar]
  5. Linde-Forsberg, C.; Eneroth, A. Abnormalities in pregnancy, parturition, and the periparturient period. In Textbook of Veterinary Internal Medicine, 6th ed.; Ettinger, S.J., Feldmann, E.C., Eds.; WB Saunders: Philadelphia, PA, USA, 2005; Volume 5, pp. 1655–1667. [Google Scholar]
  6. Münnich, A.; Küchenmeister, U. Dystocia in Numbers—Evidence-Based Parameters for Intervention in the Dog: Causes for Dystocia and Treatment Recommendations. Reprod. Domest. Anim. 2009, 44, 141–147. [Google Scholar] [CrossRef]
  7. Prashantkumar, K.A.; Walikar, A. Evaluation of treatment protocols for complete primary uterine inertia in female dogs. Pharm. Innov. J. 2018, 7, 661.e4. [Google Scholar]
  8. Gaudet, D. Retrospective study of 128 cases of canine dystocia. J. Am. Anim. Hosp. Assoc. 1985, 21, 813–818. [Google Scholar]
  9. Bergström, A.; Nødtvedt, A.; Lagerstedt, A.S.; Egenvall, A. Incidence and Breed Predilection for Dystocia and Risk Factors for Cesarean Section in a Swedish Population of Insured Dogs. Vet. Surg. 2006, 35, 786–791. [Google Scholar] [CrossRef]
  10. Bergström, A.; Fransson, B.; Lagerstedt, A.S.; Olsson, K. Primary uterine inertia in 27 bitches: Aetiology and treatment. J. Small Anim. Pract. 2006, 47, 456–460. [Google Scholar] [CrossRef]
  11. Bennett, D. Canine dystocia—A review of the literature. J. Small Anim. Pract. 1974, 15, 101–117. [Google Scholar] [CrossRef]
  12. Johnston, S.D.; Root Kustritz, M.V.; Olson, P.S. Canine and Feline Theriogenology, 1st ed.; WB Saunders: Philadelphia, PA, USA, 2001. [Google Scholar]
  13. Gill, M.A. Perinatal and Late Neonatal Mortality in the Dog. Ph.D. Thesis, University of Sydney, Sydney, Australia, 2001. [Google Scholar]
  14. Hollinshead, F.K.; Hanlon, D.W.; Gilbert, R.O.; Verstegen, J.P.; Krekeler, N.; Volkmann, D.H. Calcium, parathyroid hormone, oxytocin and pH profiles in the whelping bitch. Theriogenology 2010, 73, 1276–1283. [Google Scholar] [CrossRef]
  15. Frehner, B.; Reichler, I.; Keller, S.; Goericke-Pesch, S.; Balogh, O. Blood calcium, glucose and haematology profiles of parturient bitches diagnosed with uterine inertia or obstructive dystocia. Reprod. Domest. Anim. 2018, 53, 680–687. [Google Scholar] [CrossRef]
  16. Egloff, S.; Reichler, I.M.; Kowalewski, M.P.; Keller, S.; Goericke-Pesch, S.; Balogh, O. Uterine expression of smooth muscle alpha- and gamma-actin and smooth muscle myosin in bitches diagnosed with uterine inertia and obstructive dystocia. Theriogenology 2020, 156, 162–170. [Google Scholar] [CrossRef]
  17. Frehner, B.L.; Reichler, I.M.; Kowalewski, M.P.; Gram, A.; Keller, S.; Goericke-Pesch, S.; Balogh, O. Implications of the RhoA/Rho associated kinase pathway and leptin in primary uterine inertia in the dog. J. Reprod. Dev. 2021, 67, 207–215. [Google Scholar] [CrossRef]
  18. Naaktgeboren, C.; Slijper, E.J. Biologie der Geburt: Eine Einführung in die Vergleichende Geburtskunde, 1st ed.; Paul Parey: Hamburg, Germany, 1970; pp. 67–160. [Google Scholar]
  19. Purohit, G.N. Parturition in Domestic Animals: A Review. WebmedCentral Reprod. 2010, 1, WMC00748. [Google Scholar]
  20. Bergström, A.; Fransson, B.; Lagerstedt, A.S.; Kindahl, H.; Olsson, U.; Olsson, K. Hormonal concentrations in bitches with primary uterine inertia. Theriogenology 2010, 73, 1068–1075. [Google Scholar] [CrossRef]
  21. Baan, M.; Taverne, M.A.; de Gier, J.; Kooistra, H.S.; Kindahl, H.; Dieleman, S.J.; Okkens, A.C. Hormonal changes in spontaneous and aglépristone-induced parturition in dogs. Theriogenology 2008, 69, 399–407. [Google Scholar] [CrossRef]
  22. Hoffmann, B.; Höveler, R.; Nohr, B.; Hasan, S.H. Investigations on hormonal changes around parturition in the dog and the occurrence of pregnancy-specific non conjugated oestrogens. Exp. Clin. Endocrinol. 1994, 102, 185–189. [Google Scholar] [CrossRef]
  23. Hinderer, J.; Lüdeke, J.; Riege, L.; Haimerl, P.; Bartel, A.; Kohn, B.; Weber, C.; Müller, E.; Arlt, S.P. Progesterone Concentrations during Canine Pregnancy. Animals 2021, 11, 3369. [Google Scholar] [CrossRef]
  24. Concannon, P.W.; McCann, J.P.; Temple, M. Biology and endocrinology of ovulation, pregnancy and parturition in the dog. J. Reprod. Fertil. Suppl. 1989, 39, 3–25. [Google Scholar]
  25. Hoffmann, B.; Höveler, R.; Hasan, S.H.; Failing, K. Ovarian and pituitary function in dogs after hysterectomy. J. Reprod. Fertil. 1992, 96, 837–845. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Nohr, B.; Hoffmann, B.; Steinetz, B.E. Investigation of the endocrine control of parturition in the dog by application of an antigestagen. J. Reprod. Fertil. Suppl. 1993, 47, 542–543. [Google Scholar] [PubMed]
  27. Kowalewski, M.P.; Tavares Pereira, M.; Kazemian, A. Canine conceptus-maternal communication during maintenance and termination of pregnancy, including the role of species-specific decidualization. Theriogenology 2020, 150, 329–338. [Google Scholar] [CrossRef] [PubMed]
  28. Kowalewski, M.P. Luteal regression vs. prepartum luteolysis: Regulatory mechanisms governing canine corpus luteum function. Reprod. Biol. 2014, 14, 89–102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Van der Weyden, G.C.; Taverne, M.A.; Dieleman, S.J.; Wurth, Y.; Bevers, M.M.; van Oord, H. Physiological aspects of pregnancy and parturition in dogs. J. Reprod. Fertil. Suppl. 1989, 39, 211–224. [Google Scholar] [PubMed]
  30. Irons, P.C.; Nöthling, J.O.; Volkmann, D.H. Failure of luteolysis leads to prolonged gestation in a bitch: A case report. Theriogenology 1997, 48, 353–359. [Google Scholar] [CrossRef]
  31. McLean, L. Single pup syndrome in an English Bulldog: Failure of luteolysis. Companion Anim. 2012, 17, 17–20. [Google Scholar] [CrossRef]
  32. Tamminen, T.; Sahlin, L.; Masironi-Malm, B.; Dahlbom, M.; Katila, T.; Taponen, J.; Laitinen-Vapaavuori, O. Expression of uterine oxytocin receptors and blood progesterone, 13,14-dihydro-15-Keto-Prostaglandin F2α, and ionized calcium levels in dystocic bitches. Theriogenology 2019, 135, 38–45. [Google Scholar] [CrossRef]
  33. Derussi, A.; De Souza, R.; Volpato, R.; Guaitolini, C.; Ackermann, C.; Taffarel, M.; Cardoso, G.; Dal-Pai-Silva, M.; Lopes, M. Progesterone (PR), Oestrogen (ER-α and ER-β) and Oxytocin (OTR) Gene Expression in the Oviduct and Uterus of Pregnant and Non-Pregnant Bitches. Reprod. Domest. Anim. 2012, 47, 197–199. [Google Scholar] [CrossRef]
  34. Kowalewski, M. Endocrine and Molecular Control of Luteal and Placental Function in Dogs: A Review. Reprod. Domest. Anim. 2012, 47, 19–24. [Google Scholar] [CrossRef]
  35. Hoffmann, B.; Büsges, F.; Engel, E.; Kowalewski, M.P.; Papa, P. Regulation of corpus luteum-function in the bitch. Reprod. Domest. Anim. 2004, 39, 232–240. [Google Scholar] [CrossRef]
  36. Papa, P.C.; Kowalewski, M.P. Factors affecting the fate of the canine corpus luteum: Potential contributors to pregnancy and non-pregnancy. Theriogenology 2020, 150, 339–346. [Google Scholar] [CrossRef]
  37. Papa, P.C.; Hoffmann, B. The corpus luteum of the dog: Source and target of steroid hormones? Reprod. Domest. Anim. 2011, 46, 750–756. [Google Scholar] [CrossRef]
  38. Arrowsmith, S.; Wray, S. Oxytocin: Its Mechanism of Action and Receptor Signalling in the Myometrium. J. Neuroendocrinol. 2014, 26, 356–369. [Google Scholar] [CrossRef]
  39. Ferguson, J.K.W. A study of the motility of the intact uterus at term. Surg. Gynecol. Obstet. 1941, 73, 359–366. [Google Scholar]
  40. Gram, A.; Boos, A.; Kowalewski, M.P. Uterine and placental expression of canine oxytocin receptor during pregnancy and normal and induced parturition. Reprod. Domest. Anim 2014, 49 (Suppl. S2), 41–49. [Google Scholar] [CrossRef]
  41. Veiga, G.A.; Milazzotto, M.P.; Nichi, M.; Lúcio, C.F.; Silva, L.C.; Angrimani, D.S.; Vannucchi, C.I. Gene expression of estrogen and oxytocin receptors in the uterus of pregnant and parturient bitches. Braz. J. Med. Biol. Res. 2015, 48, 339–343. [Google Scholar] [CrossRef] [Green Version]
  42. Olsson, K.; Bergström, A.; Kindahl, H.; Lagerstedt, A.S. Increased plasma concentrations of vasopressin, oxytocin, cortisol and the prostaglandin F2alpha metabolite during labour in the dog. Acta Physiol. Scand. 2003, 179, 281–287. [Google Scholar] [CrossRef]
  43. Fuchs, A.R.; Rust, W.; Fields, M.J. Accumulation of cyclooxygenase-2 gene transcripts in uterine tissues of pregnant and parturient cows: Stimulation by oxytocin. Biol. Reprod. 1999, 60, 341–348. [Google Scholar] [CrossRef] [Green Version]
  44. Meier, S.; Lau, T.M.; Jenkin, G.; Fairclough, R.J. Oxytocin-induced prostaglandin F2 alpha release and endometrial oxytocin receptor concentrations throughout pregnancy in ewes. J. Reprod. Fertil. 1995, 103, 233–238. [Google Scholar] [CrossRef] [Green Version]
  45. Rempel, L.M.; Körber, H.; Reichler, I.M.; Balogh, O.; Goericke-Pesch, S. Investigations on the potential role of prostaglandin E2 in canine uterine inertia. Theriogenology 2021, 175, 134–147. [Google Scholar] [CrossRef]
  46. Rempel, L.M.; Lillevang, K.T.A.; Straten, A.-K.T.; Friðriksdóttir, S.B.; Körber, H.; Wehrend, A.; Kowalewski, M.P.; Reichler, I.M.; Balogh, O.; Goericke-Pesch, S. Do uterine PTGS2, PGFS, and PTGFR expression play a role in canine uterine inertia? Cell Tissue Res. 2021, 385, 251–264. [Google Scholar] [CrossRef] [PubMed]
  47. Fusi, J.; Veronesi, M.C. Canine parturition: What is known about the hormonal setting? Domest. Anim. Endocrinol. 2022, 78, 106687. [Google Scholar] [CrossRef]
  48. Arlt, S.P. The bitch around parturition. Theriogenology 2020, 150, 452–457. [Google Scholar] [CrossRef] [PubMed]
  49. Phaneuf, S. Desensitization of oxytocin receptors in human myometrium. Hum. Reprod. Update 1998, 4, 625–633. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Kowalewski, M.P.; Gram, A.; Kautz, E.; Graubner, F.R. The Dog: Nonconformist, Not Only in Maternal Recognition Signaling. Adv. Anat. Embryol. Cell Biol. 2015, 216, 215–237. [Google Scholar]
  51. Tamminen, T.M.; Sahlin, L.; Masironi, B.; Taponen, J.; Laitinen-Vapaavuori, O.; Katila, T. Oxytocin receptors in dioestrous and anoestrous canine uteri. Reprod. Domest. Anim. 2017, 52, 153–159. [Google Scholar] [CrossRef]
  52. Prapaiwan, N.; Manee-in, S.; Olanratmanee, E.; Srisuwatanasagul, S. Expression of oxytocin, progesterone, and estrogen receptors in the reproductive tract of bitches with pyometra. Theriogenology 2017, 89, 131–139. [Google Scholar] [CrossRef]
  53. Taylor, C.R.; Levenson, R.M. Quantification of immunohistochemistry—Issues concerning methods, utility and semiquantitative assessment II. Histopathology 2006, 49, 411–424. [Google Scholar] [CrossRef]
  54. Uvnäs-Moberg, K.; Stock, S.; Erikson, M.; Lindén, A.; Einarsson, S.; Kunavongkrit, A. Plasma levels of oxytocin increase in response to suckling and feeding in dogs and sows. Acta Physiol. Scand. 1985, 124, 391–398. [Google Scholar] [CrossRef]
  55. El Alj, A.; Bonoris, E.; Cynober, E.; Germain, G. Heterogeneity of oxytocin receptors in the pregnant rat myometrium near parturition. Eur. J. Pharmacol. 1990, 186, 231–238. [Google Scholar] [CrossRef]
  56. Lambert, F.L.; Pelletier, G.; Dufour, M.; Fortier, M.A. Specific properties of smooth muscle cells from different layers of rabbit myometrium. Am. J. Physiol. 1990, 258, C794–C802. [Google Scholar] [CrossRef]
  57. Taneike, T.; Miyazaki, H.; Nakamura, H.; Ohga, A. Autonomic innervation of the circular and longitudinal layers in swine myometrium. Biol. Reprod. 1991, 45, 831–840. [Google Scholar] [CrossRef] [Green Version]
  58. Gorriz Martin, L. An In Vitro Study on the Myometrial Contractility in Dairy Cattle before Calving and after Postpartum LPS Infusion. Relation to Blood Progesterone and Estradiol-17β Levels. Ph.D. Thesis, University of Veterinary Medicine Hannover, Hannover, Germany, 2013. [Google Scholar]
  59. Doualla-Bell, F.; Lye, S.J.; Labrie, F.; Fortier, M.A. Differential expression and regulation of connexin-43 and cell-cell coupling in myocytes from the circular and longitudinal layers of bovine myometrium. Endocrinology 1995, 136, 5322–5328. [Google Scholar] [CrossRef]
  60. Jungmann, C.; Mazzuoli-Weber, G.; Goericke-Pesch, S. Insight into canine uterine inertia—The organ bath as an ex vivo method for studying the contraction behaviour of canine pregnant myometrium responding to Oxytocin—Preliminary results. In Proceedings of the 23rd European Veterinary Society for Small Animal Reproduction (EVSSAR) Congress, Milano, Italy, 1–2 October 2021; Volume 57, p. 23. [Google Scholar]
  61. Gogny, A.; Mallem, Y.; Destrumelle, S.; Thorin, C.; Desfontis, J.C.; Gogny, M.; Fiéni, F. In vitro comparison of myometrial contractility induced by aglepristone-oxytocin and aglepristone-PGF2alpha combinations at different stages of the estrus cycle in the bitch. Theriogenology 2010, 74, 1531–1538. [Google Scholar] [CrossRef]
  62. Taverne, M.A.; Naaktgeboren, C.; Elsaesser, F.; Forsling, M.L.; van der Weyden, G.C.; Ellendorff, F.; Smidt, D. Myometrial electrical activity and plasma concentrations of progesterone, estrogens and oxytocin during late pregnancy and parturition in the miniature pig. Biol. Reprod. 1979, 21, 1125–1134. [Google Scholar] [CrossRef]
  63. Taverne, M.A.; van der Weyden, G.C.; Fontijne, P.; Ellendorff, F.; Naaktgeboren, C.; Smidt, D. Uterine position and presentation of minipig-fetuses and their order and presentation at birth. Am. J. Vet. Res. 1977, 38, 1761–1764. [Google Scholar]
  64. Taverne, M.A.M.; Naaktgeboren, C.; van der Weyden, G.C. Myometrial activity and expulsion of fetuses. Anim. Reprod. Sci. 1979, 2, 117–131. [Google Scholar] [CrossRef]
  65. Fuller, G.; McGee, G.; Nelson, J.; Willis, D.; Culpepper, J. Birth sequence in mice. Lab. Anim. Sci. 1976, 26, 198–200. [Google Scholar]
  66. Van Engelen, E.; Taverne, M.A.M.; Everts, M.E.; van der Weijden, G.C.; Doornenbal, A.; Breeveld-Dwarkasing, V.N.A. EMG activity of the muscular and stromal layer of the cervix in relation to EMG activity of the myometrium and cervical dilatation in PGF2α induced parturition in the cow. Theriogenology 2007, 67, 1158–1167. [Google Scholar] [CrossRef]
  67. Taverne, M.A.; van der Weijden, G.C. Parturition in domestic animals: Targets for future research. Reprod. Domest. Anim. 2008, 43 (Suppl. S5), 36–42. [Google Scholar] [CrossRef]
  68. Van der Weyden, G.C.V.; Taverne, M.A.M.; Okkens, A.C.; Fontijne, P. The intra-uterine position of canine foetuses and their sequence of expulsion at birth. J. Small Anim. Pract. 1981, 22, 503–510. [Google Scholar] [CrossRef] [PubMed]
  69. Peavey, M.C.; Wu, S.-P.; Li, R.; Liu, J.; Emery, O.M.; Wang, T.; Zhou, L.; Wetendorf, M.; Yallampalli, C.; Gibbons, W.E.; et al. Progesterone receptor isoform B regulates the Oxtr-Plcl2-Trpc3 pathway to suppress uterine contractility. Proc. Natl. Acad. Sci. USA 2021, 118, e2011643118. [Google Scholar] [CrossRef] [PubMed]
  70. Gracanin, A.; De Gier, J.; Zegers, K.; Bominaar, M.; Rutteman, G.; Schaefers-Okkens, A.; Kooistra, H.; Mol, J. Progesterone Receptor Isoforms in the Mammary Gland of Cats and Dogs. Reprod. Domest. Anim. 2012, 47, 313–317. [Google Scholar] [CrossRef] [PubMed]
  71. Vermeirsch, H.; Simoens, P.; Lauwers, H. Immunohistochemical detection of the estrogen receptor-α and progesterone receptor in the canine pregnant uterus and placental labyrinth. Anatom. Rec. 2000, 260, 42–50. [Google Scholar] [CrossRef]
  72. Kautz, E.; de Carvalho Papa, P.; Reichler, I.M.; Gram, A.; Boos, A.; Kowalewski, M.P. In vitro decidualisation of canine uterine stromal cells. Reprod. Biol. Endocrinol. 2015, 13, 85. [Google Scholar] [CrossRef] [Green Version]
  73. Hoffmann, B.; Kyrein, H.J.; Ender, M.L. An efficient procedure for the determination of progesterone by radioimmunoassay applied to bovine peripheral plasma. Horm. Res. 1973, 4, 302–310. [Google Scholar] [CrossRef]
  74. Borge, K.S.; Tønnessen, R.; Nødtvedt, A.; Indrebø, A. Litter size at birth in purebred dogs—A retrospective study of 224 breeds. Theriogenology 2011, 75, 911–919. [Google Scholar] [CrossRef]
  75. Nowak, M.; Aslan, S.; Kowalewski, M.P. Determination of novel reference genes for improving gene expression data normalization in selected canine reproductive tissues—A multistudy analysis. BMC Vet. Res. 2020, 16, 1–12. [Google Scholar] [CrossRef]
  76. Körber, H.; Goericke-Pesch, S. Expression of PTGS2, PGFS and PTGFR during downregulation and restart of spermatogenesis following GnRH agonist treatment in the dog. Cell Tissue Res. 2019, 375, 531–541. [Google Scholar] [CrossRef]
  77. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29, e45. [Google Scholar] [CrossRef]
  78. Hellemans, J.; Mortier, G.; De Paepe, A.; Speleman, F.; Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8, R19. [Google Scholar] [CrossRef] [Green Version]
  79. Jakobsson, U.; Westergren, A. Statistical methods for assessing agreement for ordinal data. Scand. J. Caring Sci. 2005, 19, 427–431. [Google Scholar] [CrossRef]
Figure 1. Serum P4 concentrations (ng/mL) immediately before C-section in bitches with primary uterine inertia (PUI) and obstructive dystocia (OD). Results presented as mean ± SD.
Figure 1. Serum P4 concentrations (ng/mL) immediately before C-section in bitches with primary uterine inertia (PUI) and obstructive dystocia (OD). Results presented as mean ± SD.
Ijms 23 13601 g001
Figure 2. Interplacental (IP) (a,b,d) and uteroplacental (UP) (c) OXTR mRNA expression (ratio) in bitches diagnosed with (a,c) PUI (n = 11) or (b) PUI-N (n = 4), respectively, and OD (n = 8). (d) OXTR mRNA expression differentiating uterine inertia subgroups according to litter size (PUI-S: n = 4; PUI-N: n = 4; PUI-L: n = 3). (e) OXTR mRNA expression summarized for both groups (PUI + OD) for comparison of location (IP versus UP). Results presented as mean ± SD. Bars with asterisks differ significantly (** p < 0.01).
Figure 2. Interplacental (IP) (a,b,d) and uteroplacental (UP) (c) OXTR mRNA expression (ratio) in bitches diagnosed with (a,c) PUI (n = 11) or (b) PUI-N (n = 4), respectively, and OD (n = 8). (d) OXTR mRNA expression differentiating uterine inertia subgroups according to litter size (PUI-S: n = 4; PUI-N: n = 4; PUI-L: n = 3). (e) OXTR mRNA expression summarized for both groups (PUI + OD) for comparison of location (IP versus UP). Results presented as mean ± SD. Bars with asterisks differ significantly (** p < 0.01).
Ijms 23 13601 g002
Figure 3. OXTR protein localization as revealed by IHC staining in canine uterine interplacental tissue. (a) myometrium, circular layer; (b) myometrium, longitudinal layer; (c) isotype control for OXTR given as inset. Independent of groups, myocytes (➔ black bold arrow) stained significantly stronger in the circular myometrial layer compared to the longitudinal one.
Figure 3. OXTR protein localization as revealed by IHC staining in canine uterine interplacental tissue. (a) myometrium, circular layer; (b) myometrium, longitudinal layer; (c) isotype control for OXTR given as inset. Independent of groups, myocytes (➔ black bold arrow) stained significantly stronger in the circular myometrial layer compared to the longitudinal one.
Ijms 23 13601 g003
Figure 4. Comparison of OXTR IP staining intensity between myometrial layers (longitudinal/circular) for (a) PUI (n = 12) and (b) OD (n = 8), respectively, and (c) regardless of the group (PUI + OD). Results presented as mean ± SD. Bars with asterisks differ significantly (*** p < 0.001).
Figure 4. Comparison of OXTR IP staining intensity between myometrial layers (longitudinal/circular) for (a) PUI (n = 12) and (b) OD (n = 8), respectively, and (c) regardless of the group (PUI + OD). Results presented as mean ± SD. Bars with asterisks differ significantly (*** p < 0.001).
Ijms 23 13601 g004
Figure 5. Interplacental (IP) (a,b,d) and uteroplacental (UP) (c) PGR mRNA-expression (ratio) comparing (a,c) PUI (IP n = 11; UP n = 4) or (b) PUI-N (IP only, n = 4), respectively, and OD (IP n = 8; UP n = 5). (d) PGR mRNA expression differentiating uterine inertia subgroups according to litter size (PUI-S: n = 4; PUI-N: n = 4; PUI-L: n = 3). (e) PGR mRNA expression summarized for both groups (PUI + OD) for comparison of location (IP versus UP). Results are shown as mean ± SD. Bars with asterisk differ significantly (* p < 0.05); a trend (p = 0.0524) is also given.
Figure 5. Interplacental (IP) (a,b,d) and uteroplacental (UP) (c) PGR mRNA-expression (ratio) comparing (a,c) PUI (IP n = 11; UP n = 4) or (b) PUI-N (IP only, n = 4), respectively, and OD (IP n = 8; UP n = 5). (d) PGR mRNA expression differentiating uterine inertia subgroups according to litter size (PUI-S: n = 4; PUI-N: n = 4; PUI-L: n = 3). (e) PGR mRNA expression summarized for both groups (PUI + OD) for comparison of location (IP versus UP). Results are shown as mean ± SD. Bars with asterisk differ significantly (* p < 0.05); a trend (p = 0.0524) is also given.
Ijms 23 13601 g005
Figure 6. Specific immunostaining for PGR revealed in canine uterine tissue. (a,b,d): IP, (c,e): UP. (a,b,d,e): Myometrium; (a,d): Stratum circulare; (b): Stratum longitudinale; (c): Placenta. Strong immunopositive signals for PGR are visible in myocytes (➔, black bold arrow) of both myometrial layers and maternal decidual cells (⇨, white bold arrow) in the placenta in the PUI group (ac). Myometrial staining appears weaker in OD (d) (representative image from the OD group). (e) The isotype control is devoid of signals (insert).
Figure 6. Specific immunostaining for PGR revealed in canine uterine tissue. (a,b,d): IP, (c,e): UP. (a,b,d,e): Myometrium; (a,d): Stratum circulare; (b): Stratum longitudinale; (c): Placenta. Strong immunopositive signals for PGR are visible in myocytes (➔, black bold arrow) of both myometrial layers and maternal decidual cells (⇨, white bold arrow) in the placenta in the PUI group (ac). Myometrial staining appears weaker in OD (d) (representative image from the OD group). (e) The isotype control is devoid of signals (insert).
Ijms 23 13601 g006
Figure 7. Interplacental myometrial staining score (IP-Myoscore) for PGR in PUI (n = 12), PUI-N (n = 4), and OD (n = 8) as obtained by immunohistochemistry. Comparison of IP-Myoscore of (a) PUI or (b) PUI-N, respectively, and OD and (c) within PUI subgroups according to litter size. Results are presented as geometric means with dispersion factor. Asterisks show significant differences (* p < 0.05).
Figure 7. Interplacental myometrial staining score (IP-Myoscore) for PGR in PUI (n = 12), PUI-N (n = 4), and OD (n = 8) as obtained by immunohistochemistry. Comparison of IP-Myoscore of (a) PUI or (b) PUI-N, respectively, and OD and (c) within PUI subgroups according to litter size. Results are presented as geometric means with dispersion factor. Asterisks show significant differences (* p < 0.05).
Ijms 23 13601 g007
Table 1. Sequence of primers for RT-PCR and RT-qPCR, amplicon length, efficiency, and accession number.
Table 1. Sequence of primers for RT-PCR and RT-qPCR, amplicon length, efficiency, and accession number.
PrimerAccession Nr.Forward
Sequence
(5′→3′)
Reverse
Sequence
(5′→3′)
Amplicon Length (bp)Efficiency
OXTRNM_001198659.1GGATCACGCTCTCCGTCTACACGTCTTGAGTCGCAGGTTCTG982.08
PGRNM_001003074.1CGAGTCATTACCTCAGAAGATTTGTTTCTTCCATTGCCCTTTTAAAGAAGA1132.07
PTK2XM_038685127.1AGATGCTGACCGCTGCTCATTCAGTGTGGCCTCGTTGGTC1041.98
GAPDHNM_001003142GGCCAAGAGGGTCATCATCTCGGGGCCGTCCACGGTCTTC2291.93
EIF4HXM_038667880.1GGAGTGTGCGGCTAGTCAGAACCCAACAGTGCACCATCGTA1991.97
KDM4AXM_038687969.1CCCGGCGGTGGATTGAGTATAACTCGGCTGCTTCTGGTGT1812.04
Table 2. Overview of primary and secondary antibodies used for IHC. Stock Keeping Unit (SKU) and producer given (* Abcam, Cambridge, UK; ** Thermo Fisher Scientific, Waltham, MA, USA; *** Vector Laboratories Burlingame, CA, USA).
Table 2. Overview of primary and secondary antibodies used for IHC. Stock Keeping Unit (SKU) and producer given (* Abcam, Cambridge, UK; ** Thermo Fisher Scientific, Waltham, MA, USA; *** Vector Laboratories Burlingame, CA, USA).
AntibodySourceCloneDilution (µg/µL)SKUSecondary AntibodyIsotype Control
OXTRRabbitMonoclonal0.02ab217212 *n.a. 1Rabbit IgG ***
(I-1000
Control Antibody)
PGRMouseMonoclonal0.02PRAT 4.14 **Horse anti-mouse ***
(BA-2000)
Mouse IgG ***
(I-2000
Control Antibody)
n.a. 1: not applicable as the SuperVision 2 HRP KIT PD000KIT was used.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Jungmann, C.; Houghton, C.G.; Nielsen, F.G.; Packeiser, E.-M.; Körber, H.; Reichler, I.M.; Balogh, O.; Goericke-Pesch, S. Involvement of Oxytocin and Progesterone Receptor Expression in the Etiology of Canine Uterine Inertia. Int. J. Mol. Sci. 2022, 23, 13601. https://doi.org/10.3390/ijms232113601

AMA Style

Jungmann C, Houghton CG, Nielsen FG, Packeiser E-M, Körber H, Reichler IM, Balogh O, Goericke-Pesch S. Involvement of Oxytocin and Progesterone Receptor Expression in the Etiology of Canine Uterine Inertia. International Journal of Molecular Sciences. 2022; 23(21):13601. https://doi.org/10.3390/ijms232113601

Chicago/Turabian Style

Jungmann, Carolin, Caroline Gauguin Houghton, Frederik Goth Nielsen, Eva-Maria Packeiser, Hanna Körber, Iris M. Reichler, Orsolya Balogh, and Sandra Goericke-Pesch. 2022. "Involvement of Oxytocin and Progesterone Receptor Expression in the Etiology of Canine Uterine Inertia" International Journal of Molecular Sciences 23, no. 21: 13601. https://doi.org/10.3390/ijms232113601

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop